Day: January 10, 2025
Advancing Multiple Programs in Areas of Significant Unmet Medical Need
Several Milestones Across Clinical Development Pipeline Expected in 2025
HOUSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, today provides a clinical development and operational update for 2025.
“The important work we conducted throughout 2024 has led us into what we believe is an exciting 2025 as we build off positive data generated in oncology and the addition of a new application for BP1001-A in the treatment of obesity for Type 2 Diabetes. This new application compels us to advance these studies as quickly as possible and to file for regulatory designations...
EnviroGold Global Announces the Upsizing of Its Unit Offering to Raise Up to $4 Million in Response to Investor Interest
Written by Customer Service on . Posted in Public Companies.
TORONTO, Jan. 10, 2025 (GLOBE NEWSWIRE) — EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold,” or the “Company”), a technology company enabling the global mining industry to monetize valuable metals contained in mine waste and tailings, reduce environmental liabilities and improve social and environmental outcomes, is pleased to announce that it has increased the size of its previously announced non-brokered private placement financing due to increased investor interest, to raise up to CAD $4,000,000 of gross proceeds, consisting of up to 4,000 units (the “Units”) issued at a price of CAD$1,000 per Unit. Each Unit will consist of CAD$1,000 principal amount of unsecured convertible notes and 11,112 common share purchase warrants of the Company. All other terms of the Financing remain as set out in the Company’s...
Amplify Energy to Participate in Fireside Chat with Alliance Global Partners on January 23, 2025
Written by Customer Service on . Posted in Public Companies.
HOUSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) — Amplify Energy Corp. (“Amplify” or the “Company”) (NYSE: AMPY) announced today that management will participate in a fireside chat hosted by Jeff Grampp, Senior Analyst at Alliance Global Partners on January 23, 2025. Details of the call are provided below.
Date and Time: Thursday, January 23 at 12:00 p.m. ET
Webcast: https://us02web.zoom.us/webinar/register/WN__puxX4MVSdaiAls6CkBOow
A replay of the fireside chat will be available for at least 30 days following the event on the investor relations section of the Company’s website.
About Amplify Energy
Amplify Energy Corp. is an independent oil and natural gas company engaged in the acquisition, development, exploitation and production of oil and natural gas properties. Amplify’s operations are focused in Oklahoma, the Rockies (Bairoil),...
Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
Written by Customer Service on . Posted in Public Companies.
Substantial, Rapid and Sustained Statistically Significant Reductions of Key Biomarkers Achieved Across Doses, Including up to 80% Mean Reduction of Androstenedione
Meaningful Improvements Demonstrated in Multiple Clinical Signs and Symptoms of CAH Affecting Patient Health
Safety and Efficacy Data Support Initiation of Phase 3 Clinical Trial
Management to Host Investor Conference Call Today at 8:30 AM ET
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced positive topline results from an open-label, Phase 2 congenital adrenal hyperplasia (CAH) study of investigational atumelnant, a novel, once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist candidate being developed for the treatment of classic CAH and ACTH-dependent Cushing’s syndrome.
“These exciting results...
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Grew full-year revenue to an estimated $71.3 million, an increase of 45%
LOUISVILLE, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) — Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced its preliminary financial results for the fourth quarter and year ended December 31, 2024 (fiscal 2024). The financial results included in this release pertaining to the fourth quarter and fiscal 2024 are preliminary, unaudited, and subject to final review and adjustment.
Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial HighlightsTotal revenue is estimated to be $20.4 million and $71.3 million for the fourth quarter and fiscal 2024, respectively, an increase of 39% and 45% over the respective prior year comparable periods;Lung Diagnostics revenue is estimated to be $17.2 million and $64.7 million for...
Form 8.3 – [LEARNING TECHNOLOGIES GROUP PLC – 09 01 2025] – (CGWL)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
LEARNING TECHNOLOGIES GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date...
HSBC Bank Plc – Form 8.5 (EPT/RI) – Team Internet Group plc
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Name of exempt principal trader:
HSBC Bank Plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
Team Internet Group plc(c) Name of the party to the offer with which exempt principal trader is connected:
OFFEREE: Team Internet Group plc(d) Date dealing undertaken:
09 January 2025 (e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”
N/A 2. ...
PCI Biotech: Employee share option scheme in connection with promotion of new CSO
Written by Customer Service on . Posted in Public Companies.
Oslo, 10 January 2025 – PCI Biotech (OSE: PCIB), today announced that the Board of Directors has granted share options to Morten Luhr who has been promoted to Chief Scientific Officer (CSO) from January 2025. Anders Høgset, former CSO, will commence as Scientific Advisor in a 20% position.
In accordance with the authorisation granted by the Annual General Meeting 24 May 2024 and the remuneration policy adopted by the Annual General Meeting 28 May 2021, the Board of Directors of PCI Biotech Holding ASA (“PCI Biotech”) has awarded a total of 75,000 share options to a key employee. Each share option gives the right to subscribe for or acquire one share per option (after PCI Biotech’s choice), at a strike price of NOK 1.35, equal to the volume weighted average share price (VWAP) for the last 5 days of trade prior to the grant date. The...
Ophævelse af suspension for afdelinger under Investeringsforeningen SparDanmark Invest
Written by Customer Service on . Posted in Public Companies.
I fortsættelse af tidligere meddelelse d. 09. januar 2025 skal det herved oplyses, at det er muligt at stille indre værdier i nedenstående afdelinger, hvorfor Nykredit Portefølje Administration A/S har anmodet Nasdaq Copenhagen A/S om, at suspension ophæves. Afdeling
ISIN
Short nameBalance
DK0061530979
SDIBALKonservativ
DK0061530896
SDIKONOffensiv
DK0061531001
SDIOFFVækst
DK0061531191
SDIVKSEventuelle spørgsmål vedrørende denne meddelelse kan rettes til Portfolio Management, npa.pm@nykredit.dk eller Christian Rye Holm, CRH@nykredit.dk.
Med venlig hilsenNykredit Portefølje Administration A/S
Report by Leading Analyst Firm Shows Quadient Recorded the Fastest Growth in 2023 Among CCM Market Leaders
Written by Customer Service on . Posted in Public Companies.
Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, announces that a newly released report by market research and consulting firm IDC shows Quadient rapidly closing the gap on the top position. According to the IDC Worldwide CCM Software Market Shares, 2023 report (doc #US52774224, December 2024), Quadient’s 13.7% year-over-year revenue growth in 2023 has accelerated from its 11% growth in 2022. This is also the fastest growth among the major Customer Communications Management (CCM) vendors globally, outperforming the overall market growth.
IDC’s data shows that the total CCM market software revenue grew from $1.6 billion in 2022 to $1.72 billion in 2023, an increase of about $75.6 million or 4.6%. During this period, Quadient captured more than 30% of this market revenue...